Two-step screening may prevent incident HF in patients with diabetes and no CVD. Risk scoring followed by biomarker testing identified those who would most likely benefit from an SGLT2 inhibitor.

Diabetes management can get slightly challenging in the winter months. Read on to comprehend ways to manage insulin resistance in winter months.